Sunitinib – vom Paradigmenwechsel zu einem Therapiestandard beim metastasierten Nierenzellkarzinom (mRCC)

Publisher: Karger

E-ISSN: 2296-5262|33|1|2-4

ISSN: 2296-5270

Source: Oncology Research and Treatment, Vol.33, Iss.1, 2010-01, pp. : 2-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract